Brief: Fate Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates
05/03/2025 22:25
March 5 (Reuters) - Fate Therapeutics Inc FATE.O: FATE THERAPEUTICS Q4 NET INCOME USD -52.153 MILLION FATE THERAPEUTICS Q4 OPERATING EXPENSES USD 63.608 MILLION FATE THERAPEUTICS Q4 INCOME FROM OPERATIONS USD -61.748 MILLION FATE THERAPEUTICS Q4 COLLABORATION REVENUE USD 1.86 MILLION FATE THERAPEUTICS Q4 BASIC EPS USD -0.44 FATE THERAPEUTICS INC: PROJECTED OPERATING RUNWAY THROUGH YE26 Source text: ID:nGNX8Ys8q0 Further company coverage: FATE.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Fate Therapeutics
See all newsBrief: Fate Therapeutics Initiates Potentially Registrational RECLAIM-LN Clinical Trial Of FT819 For The Treatment Of Lupus Nephritis
Fate Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Fate Therapeutics Q2 loss narrows as expenses fall, revenue rises
Fate Therapeutics Inc expected to post a loss of 27 cents a share - Earnings Preview
Fate Therapeutics Inc expected to post a loss of 27 cents a share - Earnings Preview